CTMX CytomX Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$2,56
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,55mínimo 52 semanas
$8,21máximo 52 semanas
Capitalización Bursátil
$436M
Ingresos
$76M
tus insignias
Rango 52S
$3–$8
Calificación del Analista
BUY
Precio Objetivo
$12
P/E
·
ROE
-15.9%
Margen de Beneficio Neto
-435.2%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
CTMX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.56
Capitalización Bursátil
$436M
Ingresos
$76M
ROE
-15.9%
Rango 52S
$3–$8
CTMX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$76M2016-12-31 → 2025-12-31
Flujo de caja libre$-76M2018-12-31 → 2025-12-31
Margen neto-435.2%2018-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | CTMX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/S | 5.7promedio 5A ≈3.3 | ≈3.3 | 125.6 | Infravalorado | |
| P/B (P/C) | 4.4promedio 5A ≈-44.3 | ≈-44.3 | 2.7 | Sobrevalorado | |
| Price / FCF (Precio / FCF) | -5.7promedio 5A ≈-3.3 | ≈-3.3 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -5.8promedio 5A ≈-3.3 | ≈-3.3 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 4.4 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | CTMX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -476.2%promedio 5A ≈-52.1% | ≈-52.1% | -2083.6% | De primer nivel | |
| EBITDA Margin (Margen EBITDA) | -29.3%promedio 5A ≈-52.1% | ≈-52.1% | -2083.6% | De primer nivel | |
| Margen antes de impuestos (TTM) | -433.9%promedio 5A ≈-45.7% | ≈-45.7% | -1976.9% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | -435.2%promedio 5A ≈-46.8% | ≈-46.8% | -1978.2% | De primer nivel | |
| ROA | -12.8%promedio 5A ≈-6.6% | ≈-6.6% | -38.2% | De primer nivel | |
| ROE | -15.9%promedio 5A ≈-40.5% | ≈-40.5% | -43.9% | De primer nivel | |
| ROIC | -22.9%promedio 5A ≈-1337.5% | ≈-1337.5% | -39.0% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | CTMX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 9.4promedio 5A ≈1.8 | ≈1.8 | 10.7 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 0.3promedio 5A ≈0.6 | ≈0.6 | 7.5 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | CTMX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -44.8%promedio 5A ≈15.8% | ≈15.8% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 12.8%promedio 5A ≈27.1% | ≈27.1% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 2.2% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | CTMX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.6promedio 5A ≈0.5 | ≈0.5 | 0.0 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 29.8promedio 5A ≈20.0 | ≈20.0 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$1.1M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
2.1%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 6, 2026 | $-0.09 | $-0.08 | -13.8% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.10 | $-0.12 | 18.8% |
| 31 de diciembre de 2025 | $-0.22 | $-0.10 | -130.4% | |
| 30 de septiembre de 2025 | $-0.09 | $-0.05 | -74.4% | |
| 30 de junio de 2025 | $-0.00 | $-0.08 | 98.7% | |
| 31 de marzo de 2025 | $0.27 | $0.13 | 113.4% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76M | $138M | $101M | $53M | $37M | $68M | $27M | $60M | $72M | $15M | $8M | $5M | |
| R&D Expense | $69M | $83M | $78M | $112M | $114M | $113M | $132M | $104M | $92M | $55M | $28M | $28M | |
| SG&A Expense | $30M | $30M | $30M | $43M | $39M | $36M | $37M | $34M | $26M | $20M | $13M | $7M | |
| Operating Expenses | $99M | $113M | $108M | $154M | $153M | $149M | $168M | $137M | $118M | $75M | $41M | $35M | |
| Operating Income | $-22M | $25M | $-6M | $-101M | $-116M | $-81M | $-141M | $-78M | $-46M | $-60M | $-33M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | $2M | $487.0K | |
| Interest Income | $5M | $7M | $10M | $2M | $255.0K | $2M | $8M | $8M | $3M | $736.0K | $1M | $7.0K | |
| Other Non-op | $28.0K | $-38.0K | $-30.0K | $340.0K | $-83.0K | $-27.0K | $-135.0K | $-68.0K | $-27.0K | $-69.0K | $-2M | $-55.0K | |
| Pretax Income | $-17M | $32M | $3M | $-99M | $-116M | $-79M | $-133M | $-70M | $-44M | $-59M | $-35M | $-30M | |
| Income Tax | $238.0K | $224.0K | $4M | $0 | $0 | $-14M | $-427.0K | $14M | $-513.0K | $-19.0K | $10.0K | $10.0K | |
| Net Income | $-17M | $32M | $-569.0K | $-99M | $-116M | $-65M | $-133M | $-85M | $-43M | $-59M | $-35M | $-30M | |
| Shares (Basic) | 137,935,873 | 84,439,303 | 73,808,237 | 65,739,844 | 64,146,848 | 46,145,563 | 45,335,927 | · | · | · | · | · | |
| Shares (Diluted) | 137,935,873 | 84,745,116 | 73,808,237 | 65,739,844 | 64,146,848 | 46,145,563 | 45,335,927 | · | · | · | · | · | |
| EBITDA | $-22M | $25M | $-6M | $-101M | · | $-49M | $-111M | $-78M | · | · | $-33M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $38M | $17M | $194M | $206M | $192M | $188M | $248M | $178M | $105M | $60M | $64M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $197M | $77M | $127M | $0 | |
| Receivables | $2M | $3M | $3M | $36M | $790.0K | $798.0K | $13.0K | $97.0K | $10M | $2M | $372.0K | $2M | |
| Prepaid Expense | $5M | $4M | $5M | $7M | $4M | $7M | $7M | $9M | $4M | $4M | $2M | $482.0K | |
| Current Assets | $144M | $107M | $183M | $237M | $310M | $324M | $303M | $445M | $389M | $188M | $190M | $67M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $6M | $7M | $7M | $7M | $4M | $4M | $3M | $3M | |
| PP&E (Gross) | $18M | $19M | $19M | $19M | $20M | $18M | $16M | $14M | $9M | $8M | $6M | $5M | |
| Accum. Depreciation | $17M | $16M | $15M | $14M | $14M | $11M | $9M | $7M | $5M | $4M | $3M | $2M | |
| Goodwill | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Other Non-current Assets | $31.0K | $66.0K | $83.0K | $27.0K | $901.0K | $2M | $2M | $1M | $1M | $3M | $364.0K | $492.0K | |
| Total Assets | $152M | $121M | $202M | $261M | $339M | $359M | $341M | $457M | $398M | $199M | $197M | $73M | |
| Accounts Payable | $1M | $1M | $1M | $3M | $3M | $3M | $4M | $5M | $4M | $7M | $5M | $2M | |
| Accrued Liabilities | $14M | $12M | $18M | $24M | $34M | $23M | $30M | $27M | $16M | $9M | $5M | $2M | |
| Current Liabilities | $47M | $86M | $156M | $153M | $78M | $68M | $86M | $98M | $61M | $36M | $16M | $11M | |
| Capital Leases | $0 | $4M | $9M | $14M | $18M | $22M | $25M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $513.0K | $507.0K | $499.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $0 | · | · | $850.0K | $3M | $2M | $566.0K | $198.0K | $249.0K | |
| Total Liabilities | $53M | $121M | $249M | $347M | $340M | $366M | $290M | $326M | $328M | $121M | $71M | $75M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Common Stock | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $811M | $691M | $676M | $637M | $623M | $500M | $468M | $446M | $289M | $255M | $244M | · | |
| Retained Earnings | $-712M | $-692M | $-723M | $-723M | $-624M | $-508M | $-443M | $-315M | $-219M | $-176M | $-117M | $-78M | |
| AOCI | $111.0K | $27.0K | $95.0K | $10.0K | $-242.0K | $-47.0K | $57.0K | $-93.0K | $-94.0K | $-27.0K | $-76.0K | · | |
| Stockholders' Equity | $99M | $-456.0K | $-47M | $-86M | $-459.0K | $-8M | $25M | $136M | $70M | $78M | $126M | $-79M | |
| Liabilities + Equity | $152M | $121M | $202M | $261M | $339M | $359M | $341M | $457M | $398M | $199M | $197M | $73M | |
| Shares Outstanding | 170,186,365 | 80,099,889 | 67,310,838 | 66,228,046 | 65,392,758 | 48,251,819 | 45,523,088 | 45,083,209 | 38,478,560 | 36,490,169 | 36,033,209 | 996,520 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $2M | $2M | $2M | $1M | $783.0K | |
| Stock-based Comp | $6M | $8M | $9M | $13M | $13M | $15M | $19M | $17M | $11M | $10M | $4M | $553.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | · | $-37.0K | · | $-514.0K | $-20.0K | $8.0K | $9.0K | |
| Amort. of Intangibles | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | · | · | · | |
| Operating Cash Flow | $-76M | $-86M | $-56M | $-111M | $-119M | $5M | $-140M | $-76M | $170M | $-2M | $-27M | $32M | |
| CapEx | $220.0K | $310.0K | $840.0K | $2M | $2M | $2M | $3M | $4M | $2M | $2M | $2M | $2M | |
| Investing Cash Flow | $-60M | $100M | $-151M | $98M | $22M | $-19M | $80M | $6M | $-121M | $46M | · | · | |
| Stock Issued | $110M | $7M | · | $0 | $108M | $11M | $0 | $135M | $20M | · | · | · | |
| Net Stock Activity | $110M | $7M | · | $0 | · | $11M | · | $135M | · | · | · | · | |
| Financing Cash Flow | $110M | $8M | $30M | $648.0K | $110M | $17M | $2M | $140M | $24M | $996.0K | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $73M | $45M | $-5M | $56M | |
| Taxes Paid | · | · | · | · | $0 | $0 | $13M | · | · | · | · | · | |
| Free Cash Flow | $-76M | $-87M | $-57M | $-113M | · | $3M | $-144M | $-79M | · | · | $-29M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-31M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -29.3% | 18.1% | -6.4% | -190.6% | · | -48.4% | -192.9% | -130.9% | · | · | -430.5% | · | |
| Net Margin | -22.8% | 23.1% | -0.56% | -186.8% | · | -32.8% | -177.8% | -142.2% | · | · | -458.7% | · | |
| Pretax Margin | -22.5% | 23.2% | 3.3% | -186.8% | · | -46.6% | -178.6% | -118.2% | · | · | -458.6% | · | |
| EBITDA Margin | -29.3% | 18.1% | -6.4% | -190.6% | · | -48.4% | -192.9% | -130.9% | · | · | -430.5% | · | |
| ROA | -12.8% | 19.8% | -0.25% | -33.1% | · | -9.4% | -25.6% | -19.8% | · | · | -26.2% | · | |
| ROE | -15.9% | -266.6% | 1.1% | 119.4% | · | -67.2% | -153.5% | -58.6% | · | · | -148.9% | · | |
| ROIC | -22.9% | -5443.1% | -2.3% | 118.2% | · | -68.6% | -216.1% | -71.6% | · | · | -26.3% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 1.3 | 1.2 | 1.6 | · | 3.2 | 3.5 | 4.5 | · | · | 12.1 | · | |
| Quick Ratio | 0.3 | 0.5 | 0.1 | 1.5 | · | 1.9 | 2.2 | 2.5 | · | · | 11.9 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -19.2 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.9 | 0.4 | 0.2 | · | 0.3 | 0.1 | 0.1 | · | · | 0.1 | · | |
| Receivables Turnover | 29.8 | 42.3 | 5.1 | 2.9 | · | 247.5 | 1045.3 | 11.6 | · | · | 5.9 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.58 | $-0.01 | $-0.70 | $-1.29 | · | $1.03 | $1.12 | $2.90 | · | · | $3.50 | · | |
| Revenue / Share | $0.55 | $1.63 | $1.37 | $0.81 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.55 | $-1.02 | $-0.76 | $-1.69 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.07 | $0.48 | $0.26 | $2.92 | · | $3.98 | $4.14 | $5.49 | · | · | $1.66 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -44.8% | 36.4% | 90.4% | 42.5% | -45.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.8% | 54.7% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.2% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $76M | $138M | $101M | $53M | $37M | $68M | $27M | $60M | $72M | $15M | $8M | · | |
| Net Income TTM | $-17M | $32M | $-569.0K | $-99M | $-116M | $-65M | $-133M | $-85M | $-43M | $-59M | $-35M | · | |
| Market Cap | $725M | $83M | $104M | $106M | · | $316M | $378M | $681M | · | · | $752M | · | |
| P/S | 9.5 | 0.6 | 1.0 | 2.0 | · | 4.6 | 14.1 | 11.4 | · | · | 97.5 | · | |
| P/B | 7.3 | -180.9 | -2.2 | -1.2 | · | 6.3 | 7.4 | 5.2 | · | · | 6.0 | · | |
| P / Tangible Book | 7.4 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -9.6 | -1.0 | -1.9 | -1.0 | · | 60.1 | -2.7 | -9.0 | · | · | -27.4 | · | |
| P / FCF | -9.6 | -1.0 | -1.8 | -0.9 | · | 107.1 | -2.6 | -8.6 | · | · | -25.9 | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $10M | $663.0K | $6M | $19M | $51M | $38M | $33M | $25M | $27M | $26M | $25M | $23M | $20M | $11M | |
| R&D Expense | $18M | $19M | $21M | $15M | $13M | $19M | $15M | $21M | $25M | $19M | $16M | $21M | $21M | $20M | $30M | |
| SG&A Expense | $8M | $11M | $7M | $6M | $7M | $9M | $6M | $8M | $8M | $8M | $7M | $7M | $8M | $10M | $10M | |
| Operating Expenses | $25M | $30M | $29M | $22M | $20M | $28M | $20M | $29M | $34M | $27M | $23M | $28M | $29M | $30M | $41M | |
| Operating Income | $-24M | $-20M | $-28M | $-16M | $-1M | $23M | $18M | $4M | $-8M | $-606.0K | $3M | $-3M | $-6M | $-10M | $-30M | |
| Interest Income | $3M | $1M | $1M | $2M | $1M | $955.0K | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $732.0K | $616.0K | |
| Other Non-op | $18.0K | $-7.0K | $-5.0K | $5.0K | $17.0K | $11.0K | $-18.0K | $-7.0K | $-2.0K | $9.0K | $-7.0K | $-47.0K | $15.0K | $1.0K | $30.0K | |
| Pretax Income | $-21M | $-18M | $-26M | $-14M | $-91.0K | $24M | $19M | $6M | $-6M | $2M | $6M | $-1M | $-3M | $-9M | $-29M | |
| Income Tax | $60.0K | $59.0K | $55.0K | $58.0K | $63.0K | $62.0K | $63.0K | $61.0K | $51.0K | $1M | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $-21M | $-18M | $-27M | $-14M | $-154.0K | $24M | $19M | $6M | $-7M | $837.0K | $3M | $-1M | $-3M | $-9M | $-29M | |
| Shares (Basic) | 218,939,423 | 177,273,000 | · | 165,004,291 | 129,075,546 | 87,121,502 | · | 85,093,227 | 84,880,632 | · | 80,731,951 | 66,536,202 | 66,248,992 | · | 65,912,334 | |
| Shares (Diluted) | 218,939,423 | 177,273,000 | · | 165,004,291 | 129,075,546 | 87,150,666 | · | 85,204,709 | 84,880,632 | · | 80,991,722 | 66,536,202 | 66,248,992 | · | 65,912,334 | |
| EBITDA | $-24M | $-20M | · | $-16M | $-1M | $23M | · | $4M | $-8M | · | $3M | $-3M | $-6M | · | $-24M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $29M | $13M | $34M | $49M | $48M | $38M | $41M | $43M | $17M | $26M | $58M | $56M | $194M | $95M | |
| Receivables | $37M | $646.0K | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $36M | $2M | |
| Prepaid Expense | $4M | $6M | $5M | $4M | $5M | $5M | $4M | $3M | $3M | $5M | $5M | $5M | $7M | $7M | $4M | |
| Current Assets | $373M | $353M | $144M | $149M | $165M | $87M | $107M | $124M | $143M | $183M | $201M | $188M | $212M | $237M | $200M | |
| PP&E (Net) | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $6M | |
| PP&E (Gross) | · | · | $18M | · | · | · | $19M | · | · | $19M | · | · | · | $19M | · | |
| Accum. Depreciation | · | · | $17M | · | · | · | $16M | · | · | $15M | · | · | · | $14M | · | |
| Goodwill | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | |
| Other Non-current Assets | $31.0K | $31.0K | $31.0K | $51.0K | $56.0K | $61.0K | $66.0K | $70.0K | $76.0K | $83.0K | $87.0K | $91.0K | $27.0K | $27.0K | $895.0K | |
| Total Assets | $381M | $359M | $152M | $158M | $175M | $98M | $121M | $139M | $159M | $202M | $221M | $209M | $235M | $261M | $226M | |
| Accounts Payable | $2M | $1M | $1M | $646.0K | $227.0K | $276.0K | $1M | $1M | $611.0K | $1M | $2M | $1M | $2M | $3M | $5M | |
| Accrued Liabilities | $12M | $12M | $14M | $12M | $12M | $11M | $12M | $17M | $14M | $18M | $21M | $20M | $22M | $24M | $31M | |
| Current Liabilities | $40M | $34M | $47M | $41M | $39M | $50M | $86M | $119M | $143M | $156M | $147M | $141M | $151M | $153M | $98M | |
| Capital Leases | $4M | · | $0 | $0 | $1M | $3M | $4M | $6M | $7M | $9M | $11M | $12M | $13M | $14M | $15M | |
| Other Non-current Liabilities | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $216.0K | · | $0 | · | |
| Total Liabilities | $79M | $39M | $53M | $51M | $55M | $73M | $121M | $162M | $190M | $249M | $272M | $294M | $321M | $347M | $198M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.05B | $1.05B | $811M | $790M | $788M | $693M | $691M | $687M | $685M | $676M | $673M | $642M | $640M | $637M | $634M | |
| Retained Earnings | $-751M | $-730M | $-712M | $-682M | $-668M | $-668M | $-692M | $-710M | $-716M | $-723M | $-724M | $-727M | $-726M | $-723M | $-605M | |
| AOCI | $-196.0K | $102.0K | $111.0K | $104.0K | $33.0K | $-1.0K | $27.0K | $40.0K | $-4.0K | $95.0K | $-63.0K | $35.0K | $26.0K | $10.0K | $-795.0K | |
| Stockholders' Equity | $302M | $320M | $99M | $107M | $120M | $25M | $-456.0K | $-23M | $-31M | $-47M | $-51M | $-85M | $-87M | $-86M | $28M | |
| Liabilities + Equity | $381M | $359M | $152M | $158M | $175M | $98M | $121M | $139M | $159M | $202M | $221M | $209M | $235M | $261M | $226M | |
| Shares Outstanding | · | · | 170,186,365 | · | · | · | 80,099,889 | · | · | 67,310,838 | · | · | · | 66,228,046 | 65,950,242 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $5M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $1M | $2M | $2M | $3M | $3M | |
| Amort. of Intangibles | $36.0K | $37.0K | $37.0K | $36.0K | $37.0K | $36.0K | $37.0K | $36.0K | $37.0K | $37.0K | $36.0K | $37.0K | $36.0K | $36.0K | $37.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | |
| Operating Cash Flow | $-18M | $-26M | $-23M | $-16M | $-16M | $-21M | $-20M | $-21M | $-20M | $-22M | $-18M | $-25M | $9M | $-1M | $-34M | |
| CapEx | $0 | $0 | $201.0K | $-127.0K | $27.0K | $119.0K | $80.0K | $19.0K | $96.0K | $266.0K | $9.0K | $517.0K | $48.0K | $182.0K | $410.0K | |
| Investing Cash Flow | $6M | $-193M | $-14M | $439.0K | $-76M | $31M | $15M | $18M | $22M | $13M | $-43M | $26M | $-147M | $100M | $-410.0K | |
| Stock Issued | $56.0K | $228M | $16M | $0 | $93M | $0 | $2M | $0 | · | · | $0 | · | · | · | $0 | |
| Net Stock Activity | · | $228M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $511.0K | $234M | $17M | $253.0K | $94M | $0 | $2M | $0 | $5M | $244.0K | $30M | $317.0K | $0 | $190.0K | $0 | |
| Free Cash Flow | · | $-26M | · | · | · | $-21M | · | · | · | · | · | · | $9M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1677.1% | -191.8% | · | -264.4% | -6.9% | 44.4% | · | 12.3% | -33.7% | · | 11.8% | -13.5% | -24.1% | · | -141.5% | |
| Net Margin | -1457.4% | -177.9% | · | -238.6% | -0.83% | 46.2% | · | 17.2% | -26.0% | · | 11.3% | -4.4% | -14.1% | · | -137.7% | |
| Pretax Margin | -1453.2% | -177.3% | · | -237.7% | -0.49% | 46.3% | · | 17.3% | -25.8% | · | 22.0% | · | · | · | · | |
| EBITDA Margin | -1677.1% | -191.8% | · | -264.4% | -6.9% | 44.4% | · | 12.3% | -33.7% | · | 11.8% | -13.5% | -24.1% | · | -141.5% | |
| ROA | -7.4% | -8.0% | · | -9.6% | -0.09% | 16.6% | · | 3.2% | · | · | 1.3% | -0.46% | -1.2% | · | -7.8% | |
| ROE | -9.8% | -10.6% | · | -33.9% | -0.35% | -709.6% | · | -15.4% | · | · | -26.3% | 6.0% | 35.9% | · | -33.2% | |
| ROIC | -7.9% | -6.2% | · | -14.7% | -1.8% | 90.1% | · | -17.3% | · | · | -3.1% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.4 | 10.4 | · | 3.6 | 4.2 | 1.7 | · | 1.0 | · | · | 1.4 | 1.3 | 1.4 | · | 2.0 | |
| Quick Ratio | 1.4 | 0.9 | · | 0.9 | 1.3 | 1.0 | · | 0.4 | · | · | 0.2 | 0.4 | 0.4 | · | 1.0 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.4 | · | 0.2 | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 0.1 | 7.9 | · | 2.4 | 8.0 | 6.7 | · | 11.6 | · | · | 12.8 | 17.0 | 22.3 | · | 13.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.43 | |
| Revenue / Share | $0.01 | $0.06 | · | $0.04 | $0.14 | $0.58 | · | $0.39 | $0.30 | · | $0.33 | $0.37 | $0.35 | · | $0.26 | |
| Cash Flow / Share | · | $-0.14 | · | · | · | $-0.24 | · | · | · | · | · | · | $0.14 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.44 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $36M | · | $114M | $141M | $148M | · | · | · | · | · | · | · | · | $21M | |
| Net Income TTM | $-80M | $-59M | · | $28M | $48M | $42M | · | · | · | · | · | · | · | · | $-125M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $96M | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 4.7 | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 3.5 |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $76M | $138M | $101M | $53M | $37M |
| Margen Operativo % | -29.3% | 18.1% | -6.4% | -190.6% | · |
| Beneficio neto | $-17M | $32M | $-569.0K | $-99M | $-116M |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 3.1 | 1.3 | 1.2 | 1.6 | · |
| Ratio Rápido | 0.3 | 0.5 | 0.1 | 1.5 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-76M | $-87M | $-57M | $-113M | · |
Propietarios institucionales (13F) 187 declarantes · $841.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
187
Valor en tenencia
$841.4M
Nuevas posiciones
48
Posiciones cerradas
46
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 48 (-34 vs trimestre anterior) | 46 (+28 vs trimestre anterior) | 67 (+6 vs trimestre anterior) | 37 (+9 vs trimestre anterior) | +17.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $122 681 014 | 32 714 937 | 14,58% | Acciones |
| Kynam Capital Management, LP | $81 386 599 | 21 703 093 | 9,67% | Acciones |
| BlackRock, Inc. | $65 849 333 | 17 559 822 | 7,83% | Acciones |
| BANK OF AMERICA CORP /DE/ | $56 559 813 | 15 082 617 | 6,72% | Acciones |
| STATE STREET CORP | $44 052 135 | 11 747 236 | 5,24% | Acciones |
| PERCEPTIVE ADVISORS LLC | $39 146 944 | 10 439 185 | 4,65% | Acciones |
| VANGUARD GROUP INC | $36 105 988 | 8 475 584 | 4,29% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $31 970 464 | 8 525 457 | 3,80% | Acciones |
| Point72 Asset Management, L.P. | $29 291 374 | 7 811 033 | 3,48% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $19 383 605 | 5 168 961 | 2,30% | Acciones |
| Venrock Adviser, LLC | $18 682 965 | 4 982 124 | 2,22% | Acciones |
| BAKER BROS. ADVISORS LP | $18 659 348 | 4 975 826 | 2,22% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $17 548 248 | 4 678 716 | 2,09% | Acciones |
| Elmind Capital, LP | $17 062 500 | 4 550 000 | 2,03% | Acciones |
| Nextech Invest Ltd. | $16 687 245 | 4 449 932 | 1,98% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $15 497 411 | 4 132 643 | 1,84% | Acciones |
| Eversept Partners, LP | $13 344 364 | 3 558 497 | 1,59% | Acciones |
| UBS Group AG | $13 006 346 | 3 468 359 | 1,55% | Acciones |
| Siren, L.L.C. | $12 966 416 | 3 457 711 | 1,54% | Acciones |
| ADAR1 Capital Management, LLC | $12 619 193 | 3 365 118 | 1,50% | Acciones |
| CITADEL ADVISORS LLC | $11 664 409 | 3 110 509 | 1,39% | Acciones |
| MARSHALL WACE, LLP | $11 341 320 | 3 024 351 | 1,35% | Acciones |
| Woodline Partners LP | $7 650 788 | 2 040 210 | 0,91% | Acciones |
| GOLDMAN SACHS GROUP INC | $7 513 696 | 2 003 652 | 0,89% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $6 976 220 | 1 860 290 | 0,83% | Acciones |
| Qube Research & Technologies Ltd | $6 842 115 | 1 824 564 | 0,81% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6 566 876 | 1 751 167 | 0,78% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $6 321 862 | 1 685 830 | 0,75% | Acciones |
| NORTHERN TRUST CORP | $6 281 937 | 1 675 183 | 0,75% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $5 177 576 | 1 380 687 | 0,62% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $4 752 863 | 1 267 430 | 0,56% | Acciones |
| Seven Fleet Capital Management LP | $4 070 243 | 1 085 398 | 0,48% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $3 296 250 | 879 000 | 0,39% | Acciones |
| Ally Bridge Group (NY) LLC | $2 906 250 | 775 000 | 0,35% | Acciones |
| DV EQUITIES, LLC | $2 677 500 | 714 000 | 0,32% | Acciones |
| GILDER GAGNON HOWE & CO LLC | $2 641 586 | 704 423 | 0,31% | Acciones |
| Caption Management, LLC | $2 625 000 | 700 000 | 0,31% | Opción de compra |
| Bank of New York Mellon Corp | $2 567 022 | 684 539 | 0,31% | Acciones |
| DEUTSCHE BANK AG\ | $2 486 394 | 663 038 | 0,30% | Acciones |
| FIRST TRUST ADVISORS LP | $2 248 860 | 599 696 | 0,27% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 062 031 | 549 875 | 0,25% | Acciones |
| Ensign Peak Advisors, Inc | $1 893 956 | 505 055 | 0,23% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $1 815 833 | 484 222 | 0,22% | Acciones |
| SCHULHOFF & CO INC | $1 790 812 | 477 550 | 0,21% | Acciones |
| Exome Asset Management LLC | $1 725 251 | 460 067 | 0,21% | Acciones |
| Nuveen, LLC | $1 680 154 | 448 041 | 0,20% | Acciones |
| DAFNA Capital Management LLC | $1 644 026 | 438 407 | 0,20% | Acciones |
| Caption Management, LLC | $1 575 000 | 420 000 | 0,19% | Opción de venta |
| TWO SIGMA ADVISERS, LP | $1 429 332 | 335 524 | 0,17% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 395 000 | 372 000 | 0,17% | Opción de compra |
Informantes de la empresa 34 insiders · 17 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Sean A. Mccarthy | CEO | 17 de marzo de 2026 S | 1 078 922 | 0 | 2 | $-1 225 921 |
| Christopher Ogden | Chief Financial Officer | 15 de junio de 2026 S | 295 324 | 0 | 2 | $-129 007 |
| Carlos Campoy | Chief Financial Officer | 16 de marzo de 2023 S | 38 224 | 0 | 0 | $0 |
| Debanjan Ray | Chief Financial Officer | 25 de enero de 2019 A | 5 928 | 0 | 0 | $0 |
| Ii Robert C. Goeltz | Chief Financial Officer | 12 de mayo de 2017 M | 32 756 | 0 | 0 | $0 |
| Alejandra Carvajal | Chief Legal Officer | 3 de agosto de 2026 A | 100 000 | 0 | 0 | $0 |
| Marcia Belvin | SVP, Chief Scientific Officer | 17 de marzo de 2026 S | 300 760 | 0 | 1 | $-202 179 |
| Yu-Waye Chu | Chief Medical Officer | 17 de marzo de 2026 S | 189 446 | 0 | 1 | $-136 611 |
| Rachael Lester | Chief Business Officer | 2 de febrero de 2026 A | 20 000 | 0 | 0 | $0 |
| Lloyd A Rowland | General Counsel | 18 de marzo de 2025 S | 120 594 | 0 | 0 | $0 |
| Jeffrey B Landau | Chief Business Officer | 20 de agosto de 2024 M | 119 056 | 0 | 0 | $0 |
| Amy C. Peterson | EVP, Chief Development Officer | 16 de marzo de 2023 S | 58 433 | 0 | 0 | $0 |
| Alison L. Hannah | Chief Medical Officer | 20 de julio de 2022 S | 31 898 | 0 | 0 | $0 |
| Robin Knifsend | Principal Accounting Officer | 14 de febrero de 2020 A | 2 791 | 0 | 0 | $0 |
| William Michael Kavanaugh | CSO, Head Res.&Non-Clin. Dev. | 14 de febrero de 2020 A | 19 047 | 0 | 0 | $0 |
| Rachel Humphrey | Chief Medical Officer | 25 de enero de 2019 A | 30 234 | 0 | 0 | $0 |
| Cynthia J Ladd | Senior VP and General Counsel | 25 de enero de 2017 A | 3 000 | 0 | 0 | $0 |
| Charles S. Fuchs | Consejero | 24 de julio de 2026 A | · | 0 | 0 | $0 |
| Zhen Su | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Alan Ashworth | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Mani Mohindru | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Matthew P. Young | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Halley E Gilbert | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| James R Meyers | Consejero | 17 de junio de 2026 A | · | 0 | 0 | $0 |
| Elaine V Jones | Consejero | 17 de junio de 2026 A | 5 142 | 0 | 0 | $0 |
| Frederick W Gluck | Consejero | 15 de junio de 2022 A | 237 015 | 0 | 0 | $0 |
| John A Scarlett | Consejero | 16 de junio de 2021 A | · | 0 | 0 | $0 |
| Hoyoung Huh | Consejero | 13 de junio de 2018 A | · | 0 | 0 | $0 |
| Marion Mccourt | Consejero | 20 de junio de 2017 A | · | 0 | 0 | $0 |
| Neil Exter | Consejero | 20 de junio de 2017 A | 0 | 0 | 0 | $0 |
| Timothy M Shannon | Consejero | 29 de noviembre de 2016 S | 3 244 381 | 0 | 0 | $0 |
| Robert I Tepper | Propietario del 10% | 4 de octubre de 2017 S | 29 516 | 0 | 0 | $0 |
| Kevin P Starr | Propietario del 10% | 12 de abril de 2017 S | 31 419 | 0 | 0 | $0 |
| Hadley Harbor Master Investors (Cayman) L.P. | Propietario del 10% | 14 de octubre de 2015 C | 749 055 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 35 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,69% | 103 259 NS | 31 de julio de 2026 | N-PORT |
| IDNA · iShares Trust | 0,56% | 430 053 SH | 11 de septiembre de 2026 | Diario |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,41% | 35 484 SH | 2 de octubre de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,17% | 270 617 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,14% | 607 191 SH | 11 de septiembre de 2026 | Diario |
| FFSM · FIDELITY COVINGTON TRUST | 0,06% | 305 459 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,05% | 3 697 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 1 285 835 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 15 265 SH | 2 de octubre de 2026 | Diario |
| IWO · iShares Trust | 0,02% | 913 054 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1 024 499 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 70 221 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 104 846 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,02% | 4 590 750 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,02% | 84 673 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 146 154 SH | 2 de octubre de 2026 | Diario |
| TECB · iShares Trust | 0,01% | 17 020 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2 095 997 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 484 160 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 76 464 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 5 876 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 124 826 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 16 906 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 12 796 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 59 805 SH | 10 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 224 287 SH | 11 de septiembre de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,00% | 1 429 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 24 102 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 71 243 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 6 230 387 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 14 861 SH | 19 de agosto de 2026 | Diario |
| DFUV · Dimensional ETF Trust | 0,00% | 282 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 754 592 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 8 428 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 41 747 SH | 11 de septiembre de 2026 | Diario |
CTMX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$12.00
+368,7%
6 42,9%
Compra fuerte
7 50,0%
Compra
1 7,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
8 analistas · 2026-10-02Objetivo medio $12.25 +378,5%
← Por Debajo de Todos los Objetivos
Precio Actual $2.56
Mín$6.00
Media$12.25
Máx$16.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Analistas alcistas con CytomX Therapeutics (CTMX) a medida que CTMX anuncia una oferta de 250 millones de dólares
Yahoo Finance · 5 meses, 3 semanas atrás
CytomX Therapeutics (CTMX) Gana Confianza de Analistas por el Progreso del Ensayo
Yahoo Finance · 6 meses atrás
Jefferies Eleva el Precio Objetivo de CytomX Therapeutics (CTMX) a $16
Yahoo Finance · 6 meses, 1 semana atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026